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This paper reports the results of a single case design pilot study of a music therapy
intervention [the Active Music Engagement (AME)] for young children (age 3.51 to
4.53 years) undergoing hematopoietic stem cell transplantation (HCST) and their
caregivers. The primary aims of the study were to determine feasibility/acceptability of
the AME intervention protocol and data collection in the context of HCST. Secondary
aims were to examine caregivers’ perceptions of the benefit of AME and whether there
were changes in child and caregiver cortisol levels relative to the AME intervention.
Results indicated that the AME could be implemented in this context and that data
could be collected, though the collection of salivary cortisol may constitute an additional
burden for families. Nevertheless, data that were collected suggest that families derive
benefit from the AME, which underscores the need for devising innovative methods to
understand the neurophysiological impacts of the AME.
Keywords: music therapy, HPA axis (hypothalamus-pituitary-adrenal), cortisol, hematopoietic (stem) cell
transplantation (HCT), HSCT

INTRODUCTION
Hematopoietic stem cell transplantation (HSCT) is used to treat malignant conditions that require
high dose chemotherapy (and at times radiation therapy), as well as non-malignant conditions such
as hemoglobinopathies (Guilcher et al., 2018). HSCT is a high-intensity, complex treatment that has
many risks, with many pediatric patients and their caregivers experiencing high levels of emotional
distress during transplant. Compared with other age groups, young children undergoing HSCT and
their caregivers are at particular risk for heightened emotional distress, which is associated with
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and distal mediators of perceived family normalcy (Knafl and
Deatrick, 2002), caregiver confidence (self-efficacy) about their
ability to support their child during treatment (Steele et al.,
2003), and occurrence of independent music play between music
therapist led sessions. Outcomes specified in the model include
child outcomes (emotional distress, physical symptom distress,
cortisol, and quality of life), caregiver outcomes (emotional
distress, traumatic stress symptoms, cortisol, and quality of life),
and family function.
Investigation of biological pathways underlying the use
of music to mitigate transplant-related stress is supported
by evidence that increased hypothalamic-pituitary-adrenal
(HPA) axis activity stimulates the release and production of
inflammatory biomarkers, which in turn is associated with
negative health outcomes for people undergoing treatment
for chronic health conditions and their caregivers (Padgett
and Glaser, 2003; Glaser and Kiecolt-Glaser, 2005; Costanzo
et al., 2011). Cortisol is a steroid hormone secreted by the HPA
axis in response to acute and prolonged stress, and assaying
bodily fluids (such as blood or saliva) for cortisol is a method
commonly used to index HPA axis activity in children (Gunnar
and Quevedo, 2007). Few intervention studies have looked at
cortisol in pediatric patients with malignant or non-malignant
conditions (Lane, 1991; Walco et al., 2005; Post-White et al.,
2009), and of those only one used music (Lane, 1991) and
none involved caregivers. This is likely due to challenges
associated with cortisol collection and its interpretation during
cancer and HSCT treatment. Equally challenging is the ability
to conduct fully powered, randomized intervention trials in
low-incidence populations [such is the case with pediatric
cancer and sickle cell disease (SCD)] (Moore, 2004; Kang et al.,
2010; Rensen et al., 2017). To overcome these challenges, we
used a single-case design study, which allows for estimation
of intervention effects in small samples that are drawn from
low-incidence populations. Details of the study protocol were
published by Russ et al. (2020), with outcomes reported in
this manuscript.

physical symptom distress, as well as diminished quality of
life and family function (Kazak et al., 1997, 2005; Best et al.,
2001; Santacroce, 2002; Kazak and Baxt, 2007; Ingerski et al.,
2010; Graf et al., 2013; Virtue et al., 2014). In addition, this
acute emotional distress is related to traumatic stress symptoms
after treatment ends (Stuber et al., 1996, 1997; Kazak et al.,
1998; Hobbie et al., 2000; Kangas et al., 2002; Bruce, 2006;
Ingerski et al., 2010). To date, few interventions have been
developed to address the interrelated distress experienced by
young children and their caregivers during acute medical
treatment (Hatfield et al., 1993; Stuber et al., 1996; Kazak
et al., 1997; Robinson et al., 2007; Ingerski et al., 2010; Virtue
et al., 2014), with even fewer interventions specific to HSCT
(Robb and Hanson-Abromeit, 2014).
The active music engagement (AME) intervention uses
music play experiences to diminish stressful qualities of
the treatment environment, encouraging the use of positive
coping strategies to reduce the emotional and traumatic
distress experienced by young children (age 3–8 years) and
their caregivers (Robb, 2000; Robb et al., 2008, 2017). Early
studies established AME as beneficial in managing child
emotional distress (Robb, 2000; Robb et al., 2008, 2017) and
explored caregiver benefit (Robb et al., 2017); with an ongoing
mechanistic trial aimed at identifying behavioral, sociological,
and psychological variables responsible for change (NR015789).
To date, all of the AME studies have focused on short inpatient
admissions for chemotherapy and psychosocial mechanisms of
action. However, given the intensity and length of HSCT, we
anticipate that AME may have even greater benefit and clinical
utility in this patient population where the average inpatient
stay is 3–8 weeks. We anticipated that translation of AME
for HSCT would likely require changes to the intervention
protocol, followed by formal exploration concerning AME
feasibility/acceptability during transplant. And, in order to
expand our understanding about how active music interventions
work to mitigate transplant-related stress, we decided to also
explore the feasibility/acceptability of collecting cortisol (a stress
biomarker) from children and caregivers.
The conceptual framework for this study is based on Robb’s
Contextual Support Model of Music Therapy (Robb, 2000,
2003a,b) and further informed by Kazak’s Pediatric Medical
Traumatic Stress Model (Kazak and Baxt, 2007; see Figure 1). In
this framework, recurring events related to HSCT treatment (e.g.,
symptom distress; invasive procedures) are viewed as potentially
traumatic. Pre-existing factors (i.e., antecedents) influence
caregiver appraisal of whether an event is experienced as
traumatic or not traumatic. Research indicates that higher child
and caregiver distress during HSCT is related to demographics
(child/caregiver age, socioeconomic status) (Kazak et al., 2003;
Stevens et al., 2006), higher distress and greater traumatic stress
symptom during prior hospitalizations (Kazak and Barakat, 1997;
Best et al., 2001; Barrera et al., 2004), and disease and treatment
characteristics (diagnosis/transplant type) (Stuber et al., 1997;
Kazak et al., 1998; Hobbie et al., 2000; Langeveld et al., 2004).
As illustrated in Figure 1, the AME is designed to directly
target potential proximal mediators of child engagement and
caregiver-child interaction (Robb, 2000; Robb et al., 2017),
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Current Study
As specified in our previously published protocol, the current
study comprised two sets of aims (Russ et al., 2020). The
primary aims were to: determine feasibility/acceptability of
the AME intervention protocol during HSCT; evaluate clinical
feasibility/acceptability of collecting data in this context,
including collection of biological samples according to a rigorous
schedule required when using a single-case design; and assess
caregivers’ perspectives about the collection of these samples.
Secondary aims were to examine caregivers’ perceptions of the
benefit of AME and whether there were changes in child and
caregiver cortisol levels relative to the AME intervention.
These aims generated five specific research questions:
(1) What proportion of eligible caregiver-child dyads consent
to study participation, and what percentage of AME
sessions do these dyads complete?
(2) What self-report and biological data can be collected
during HSCT?
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FIGURE 1 | Conceptual framework. Reprinted from Russ et al. (2020).

as non-Hispanic black. Mothers ranged from 34 to 42 years of
age, whereas children ranged from 3.51 to 4.53 years of age at
the time their participation in the study began. Two children
were identified by their mothers as non-Hispanic white, one as
non-Hispanic black, and one as non-Hispanic, more than one
race. Although approximately 5% of families with children in the
city in which the study was conducted speak a language other
than English as their first language, all participants in the study
reported that English was their first language.
Children from two of the dyads were undergoing an
autologous transplant, and two children were undergoing
an allogenic transplant. In Table 1, we provide abbreviated
information for each parent/child dyad (e.g., child age, gender,
and transplant type) to assist with data interpretation, while
protecting participant anonymity.

(3) What are caregivers’ perspectives about the relative
ease/burden of biological sample collection?
(4) What are caregivers’ perceptions of the benefit (or nonbenefit) of AME for managing distress, and enhancing
family and quality of life outcomes for self and child?
(5) Are there observed changes in caregiver and/or child
cortisol levels associated with the AME intervention?

MATERIALS AND METHODS
Participants
To address these questions data were collected in a single-group
pilot study approved by the Indiana University Institutional
Review Board. To be eligible for study inclusion, children had
to be no younger than 3 years of age and no older than 8,
were required to be undergoing inpatient HSCT for a malignant
or non-malignant condition, and could not have a significant
cognitive impairment that might limit their participation.
A consistent caregiver had to agree to be present for music
therapy and data collection sessions, and both the participating
caregiver and child had to speak English. Dyads with children
undergoing autologous transplants – in which children’s own
stem cells are used – and allogenic transplants, in which stem cells
are provided by a donor, were included in the study.
Four child-caregiver dyads participated in the study. In each
case, the caregiver was the child’s mother, three of whom
identified as non-Hispanic white and one of whom identified
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Procedures
AME Therapy Sessions
All study participants were scheduled to receive two 45-min
AME sessions each week that they were hospitalized for HSCT.
All participants, regardless of transplant type, were expected
to receive a minimum of eight AME sessions over 4-weeks.
Each session was delivered to caregiver-child dyads in a private
room by a board-certified music therapist (MT-BC) with 8 years’
experience working with children in acute hospital settings.
The MT-BC tailored music-based play experiences to encourage
active engagement in and independent use of music play as a
way to manage distress. During sessions, the MT-BC provided
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TABLE 2 | Active music engagement (AME) intervention components and
theoretical principles.

TABLE 1 | Child demographics, diagnosis, and treatment.
Participant
number

Child
age

Diagnosis

1

4.53

Neuroblastoma

Autologous

Chemo only

2

3.81

Neuroblastoma

Autologous

Chemo only

No

3

3.51

Relapsed ALL

Allogeneic

Chemo only

Yes
Stage 4,
Grade III

4

3.51 Sickle cell disease

Allogeneic

Chemo only

No

Age corresponds to the child’s
participation in the study.
GVHD, graft versus host disease.

Transplant Conditioning
type
agent

age

at

the

beginning

Acute
GVHD

Intervention
component

Theoretical principles

Component 1:
music-based
play activities

(1) Predictable environment provides a structure that supports
child competence.
Therapist uses familiar music activities to provide structure and
increase child’s ability to predict what will happen in their
environment.
(2) Leveled activities help ensure success and support child
competence.
Therapist tailors physical activity requirements to meet the
individual needs of each child. Enables child success and
engagement during periods of high or fluctuating symptom
distress.
(3) Opportunities to make independent decisions support child
autonomy.
Children choose from a variety of music play activities, and each
activity includes a wide range of materials. Activities include a
wide range of materials and activity options so that the child can
make choices for self and others. Therapist uses improvisational
techniques to follow child-initiated changes in their music making
(e.g., child changes tempo or style of playing).
(4) Activities structured to support caregiver–child interaction.
Activities structure and support reciprocal caregiver–child
interactions. The therapist individualizes experiences to support
increased frequency and quality of interactions.

Component 2:
music play
resource kit

Supports independent use of music play to manage distress
between therapist-led sessions. Activities mirror content from
therapist-led sessions. The kit includes:
(1) Professional CD recording of music composed and/or
arranged specifically for the AME intervention.
(2) Age-appropriate musical instrument and play materials that
correspond to each activity.
(3) Activity cards designed to give children/caregivers at-a-glance
information on ways they can use their kit.

Component 3:
session
planning and
tip sheets

(1) Promotes caregiver competence about how children use play
to cope and ways to engage their child in music play during the
transplant period.
(2) Promotes caregiver autonomy by empowering caregivers with
skills/resources to support their child during treatment.
(3) Supports caregiver–child relationships through normalizing
music-based play activities.

No

of

their

repeated opportunities for caregivers and children to experience
competence, autonomy, and meaningful interactions.
The AME intervention had three primary components: (1)
therapist-led music-based play activities and sessions, (2) a
music play resource kit, and (3) session planning and caregiver
tip sheets (Table 2). At the start of sessions, the therapist
and caregiver used a session planning sheet to identify child
needs for that day (e.g., symptom management; movement;
developmental), which provided focus for that specific session.
This was followed by 30 min of music play with the caregiver
and child. During session closure, using caregiver tip sheets,
the music therapist would provide information about ways the
caregiver and child could use music-based play to manage distress
and maintain a sense of family normalcy while hospitalized
and at home following discharge. The child and caregiver also
received a music play resource kit to encourage independent use
of music play strategies between scheduled sessions, and at home
following discharge.
All study sessions were delivered by the same MT-BC who
was trained on study procedures and the AME protocol before
the study opened to enrollment. All sessions were audio-recorded
and the MT-BC completed quality assurance checklists following
each session to ensure consistent delivery and adherence to the
intervention protocol.

Reprinted from Russ et al. (2020).

Data Collection
Caregivers completed self- and proxy-report measures of
caregiver and child symptom distress up to 30 days prior to their
child’s HSCT admission (baseline), before and after AME sessions
2, 4, and 6, and in a clinic visit 100 days post-transplant (followup). Caregivers also completed semi-structured interviews within
2 weeks of follow-up. All measures and the semi-structured
interviews were administered by trained staff who were not
involved in the delivery of AME and interviews were audiorecorded to facilitate their transcription.
Biological data collection featured sampling of saliva (from
caregivers and children) and blood (from children only). Saliva
samples were collected up to 1 h before AME sessions, up to
1 h following, and again 1 to 3 h later using the passive drool
method (i.e., caregivers and children drooled into a collection
tube; see Törnhage, 2009). At the time of collection, participants
provided information about whether they had recently eaten or
had a drink and when they last slept. Blood was collected via
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a draw from children’s central line as part of their daily blood
collection (between 4 and 7 a.m.). These data were collected
using the same schedule on four treatment days (on which AME
sessions occurred) and four control days (on which AME sessions
did not occur) over the course of HSCT such that treatment
and control days were always 1 day apart. Collection schedules
differed for children undergoing autologous and allogenic stem
cell transplants. See Figures 2–4 for additional details.

Measures
Self- and Proxy-Report Measures
Caregivers completed eight items from the Edmonton Symptom
Assessment System (ESAS; Bruera et al., 1991; Richardson and
Jones, 2009; Hui and Bruera, 2017) eight times over the course
of the study: at baseline, before and after AME sessions 2, 4, and
6, and at follow-up. The ESAS includes nine-items that measure
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FIGURE 2 | Collection schedule for children undergoing autologous
transplant. Reprinted from Russ et al. (2020).
FIGURE 3 | Collection schedule for children undergoing allogenic transplant.
Reprinted from Russ et al. (2020).

symptom burden including physical and emotional distress.
ESAS uses an 11-point numeric rating scale (0 = no symptoms;
10 = worst possible). Caregivers were asked to rate their child’s
and their own distress using the timeframe “at this moment.”
Caregivers completed five items about their child’s symptom
distress (depression, anxiety, pain, tiredness, and nausea) and
three items about their own distress (depression, anxiety, and
tiredness). Composite indices of child and caregiver distress were
calculated as the sum of the items regarding each topic.

collection, and the value of different intervention components
(i.e., tip sheets, goal setting worksheet, and kit use).

Cortisol
Saliva samples were stored on dry ice immediately following
collection and then frozen at −80◦ C. Samples were then assayed
using an R&D Systems cortisol parameter assay. Following
collection, blood samples were sent immediately to a pathology
laboratory, where they were assayed using a Beckman Coulter
UniCel DxI800 immunoassay system. The minimum cortisol
concentration that can be detected using this assay is 0.40 µg/dL.

Semi-Structured Interviews
Interviews began with an open-ended question to capture the
overall experience (i.e., “Please tell me about your experience
of participating in the music play sessions with your child”);
followed by specific questions about perceived benefit (or nonbenefit) of AME in managing stress, experiences with saliva

Frontiers in Psychology | www.frontiersin.org
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FIGURE 4 | Simplified collection schedule for self- and proxy-report measures (ESAS), salivary cortisol, and blood cortisol. As shown in Figures 2, 3, the
correspondence of AME sessions and data collection varied for children undergoing autologous and allogenic transplants; for illustrative purposes, this figure depicts
days for a child undergoing an autologous transplant. Pre, Post, and Morning refer to the time of day during which samples were collected. Pre indicates that data
collection occurred before the AME session, whereas Post indicates collection occurred after the session (Post 1 and Post 2) are used to indicate that data were
collected twice after the session. C and T refer to control and treatment condition days within each pair of days on which data were collected for a given AME
session.

graphed and then Tau-U statistics were computed to compare all
unique pairs of cortisol data points between the treatment and
control conditions. For blood cortisol levels, the Tau-U statistics
were based on the data collected at the beginning of each day,
and the contrasts of interest were between these morning cortisol
levels of treatment versus control days. Negative values of Tau-U
indicate that levels of cortisol in blood were lower on treatment
condition days than on control days. For the salivary cortisol
levels, the Tau-U statistics were based on the area under the
curve with respect to increase (AUCI ) on treatment and control
days, given that the collection schedule (featuring three samples
on each day) allowed for values of AUCI to be calculated. The
AUCI corresponds to the change in cortisol from the initial
measurement (Pruessner et al., 2003), and therefore comparing
values of the AUCI on treatment days to control days allows us
to examine whether the amount of cortisol produced during and
following the AME session (on treatment days) differed from the
amount produced at approximately the same times on control
days, when AME did not occur. Negative values of Tau-U for
comparisons of the AUCI indicate that salivary cortisol levels
were lower relative to baseline on treatment condition days than
on control days.
Prior to the calculation of the Tau-U statistics, data were
inspected for evidence of serial conditioning effects by comparing
all unique pairs of data points within the control condition, which
would be indicated by a systematic (i.e., non-random) trend
in data points collected over the course of days corresponding
to control condition. When these effects were detected, the
Tau-U statistics were adjusted accordingly. The adjusted or
unadjusted Tau-U statistics were then used to estimate z scores
that corresponded to a standardized effect size of the treatment
on cortisol levels for each participant and the sample as a whole.56

Data Analysis
Data analysis was conducted in two phases that reflected
the primary and secondary aims of the study. A priori
thresholds for feasibility were based on prior AME studies
(see Robb et al., 2008, 2017) and reflect recruitment rates and
usable data that would be necessary in future trials. Given that
the number of children (age 3–8 years) who receive HSCT
is relatively low, we established higher thresholds (>75%) for
enrollment, session completion, and data collection. In the
first phase, the percentage of eligible child/caregiver dyads
that consented to participate in the study was calculated and
compared to a pre-determined feasibility threshold of 75%.
To address our first research question, the percentage of
AME sessions that participating families completed was also
calculated and compared to an acceptability threshold of 75%.
The reasons that eligible dyads declined participation and
planned intervention activities that did not occur as scheduled
were also reported.
To address our second research question we calculated the
percentage of planned self- and proxy-report measures that
were collected and compared these percentages to a feasibility
threshold of 75%. We also calculated the percentage of planned
saliva and blood-based cortisol samples that were collected and
the subset of these that yielded useable data. The percentage of
cortisol samples collected were compared to feasibility thresholds
for caregivers (85%) and children (75%). The percentage of
samples collected that yielded useable data were compared to
thresholds for caregivers (75%) and children (60%). Feasibility
thresholds were set lower for child cortisol samples given greater
possibility for challenges due to treatment side effects.
To address research questions three and four, semi-structured
interviews were transcribed and then subject to a deductive
content analysis54 using MaxQDA (version 18.2). Interviews were
coded for categories and concepts and agreement was obtained
by consensus. Question four was also addressed by graphing all
responses on the self- and proxy-report ESAS measures of distress
to visualize trends55 and then calculating Tau-U statistics (Parker
et al., 2011) to compare reported distress prior to AME sessions
2, 4, and 6 with distress following those sessions. In this study
negative values of Tau-U indicate that levels of distress decreased
from pre- to post-session.
The fifth and final research question was addressed in a similar
fashion, but using blood and salivary cortisol levels. All data were
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RESULTS
Phase One Analyses: Primary Aims
Study Participation and Completion
During a 4-month enrollment period, four caregiver-child dyads
were eligible to participate in the study. Of these, four (or 100%)
agreed to participate; this was 25% higher than our feasibility
threshold of 75%. One dyad (dyad 3) completed all eight AME
sessions as scheduled; two dyads completed seven sessions as
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scheduled. In one case (dyad 2) the child was discharged from
the hospital before the last session occurred, and in the other
(dyad 4) one session had to be rescheduled due to caregiver
illness. In one case (dyad 1) three sessions had to be rescheduled
because the child refused the session on the day it was to occur.
Therefore, across participants 27 of 32 sessions (84.4%) occurred
as scheduled, which exceeded the 75% feasibility threshold.
However, it is important to note two points: first, with the
exception of the final session for dyad 2 (prior to which the
child was discharged), all dyads completed eight sessions after
rescheduling; and second, that the primary caregiver (the child’s
mother) was not able to be present for five of these sessions in the
case of dyad 1 and for two sessions in the cases of dyads 3 and 4.
In these cases the child’s father or grandparent was present.

TABLE 3 | Categories, subcategories, and exemplar quotations for
semi-structured interviews.
Exemplar quotations

Category:
challenges of
saliva collection
during HSCT

So I think that in retrospect, that piece of getting, at least a child
that young, I don’t know what other, I know you did blood work
as well, maybe taking the blood work a little more frequently, as
opposed to the spit, at least for that age, (it) was a little bit
much. (parent 4)
The saliva collection was a bit much. You know what, I’m going
to be honest with you, I would have rather given blood. I would
have rather been like here, go ahead and take some blood and
let’s get this done. (parent 4)
As far as like doing the study, I would go a really long time
without eating. And so when I finally had a chance to eat and
we weren’t busy, I ate and I felt really guilty that I was messing
up the results of this study possibly. (parent 2)
I don’t know how viable it is to get a 3-year-old or a child that
young to spit. That was pretty challenging. I did feel a little, and
this is just me, a little stressed about getting (child) to spit,
getting him to actually spit. (parent 4)
she did not at all want to do this spit in the cup thing. Tried
really hard and like stressed her out. . . (parent 2)
(the questionnaire asked) Has your kid smiled? And I’m like, oh
no, not for weeks. And I didn’t even notice. It was like, oh she’s
just tired and she’s here. But then when we would do music,
she would kind of get excited and smile a little bit and get
excited and kind of giggle. And that was really, really good to
see. My first couple of times, like I started crying cause I was
like, oh, she’s happy. That was really cool. (parent 2)
(referencing session planning sheet) Today he just needs to be a
kid, because every day he needs to be a kid.
(parent 4)
. . . (when) she was kind of stressed out, she would sing in her
wagon That was huge. That’s something she had not done
before. it was like, she kinda knew, I don’t know, like instinctively
knew like singing calmed her down. So that was a really a
surprise seeing her self soothe herself with music. (parent 2)
It take the stress off, definitely trying to calm him down cause it
helps calm him when he wasn’t feeling so good. (parent 3)
She didn’t sleep for two like 2 or 3 days straight. She could not
sleep because she was in so much pain. And then [Music
Therapist] came in and did music and she fell asleep. So that
was, that was pretty magical. (parent 2)
So we’ve been. . . kind of getting him up moving. We did the
frog and the alligator more so that he would dance as opposed
to doing the books. (parent 3)
I think they were helpful information just in general. I mean it
definitely helped the different ways to see how it the different
activities would help. And what activities help with which issue.
(parent 3)

Subcategory:
parent
collection
stressful for
parents

Data Collection

Subcategory:
child collection
stressful for
parents and
children

Caregivers were scheduled to complete the self- and proxy-report
measures of distress (the ESAS items) eight times over the course
of the study (at baseline, before and after AME sessions 2, 4,
and 6, and at follow-up). Although adults other than the child’s
mother provided data when the mother was unable to do so, only
ESAS data provided by the mother was used to avoid introducing
variability due to different reporters into the analyses. The mother
provided data at four time points for dyads 1 and 2, and six time
points for dyads 3 and 4. Therefore, across all four caregivers
the measure was complete 20 out of 32 times, for a completion
rate of 62.5%, which fell below the feasibility threshold for the
sample overall; however, the feasibility threshold was reached
for dyads 3 and 4.
Saliva samples were collected from caregivers and children. As
noted above, three samples were scheduled to be collected from
both participants on each of the eight collection days. Therefore,
24 samples were to be collected from each caregiver and child.
Across the four caregivers, 69 (71.9%) of 96 possible samples
were collected, all of which were viable, meaning that cortisol
concentrations could be calculated from the samples. Three of
four caregivers provided 18 or more samples, all of which were
viable (≥75%). Two children (child 1 and child 4) provided
saliva for 54.2 and 20.8% of samples, respectively; 84.5% of these
samples were viable for child 1 and all were viable for child 4. The
remaining two children refused saliva sampling.
Blood samples were collected on all eight collection days for
all children, exceeding the feasibility threshold of 75%. Across
children, 27 of 32 samples were viable (84.4%), exceeding the
feasibility threshold of 75%. All samples that were not viable
were collected from the same child (child 2), and yielded cortisol
concentrations that fell outside the bounds of the assay.

Category: AME
intervention as
beneficial
during HSCT

Subcategory:
helpful to set
goals
Subcategory:
mitigating
emotional
distress

Subcategory:
mitigating
physical
distress
Subcategory:
kit use between
sessions
Subcategory:
using tip sheets

difficult for parents, the frequency of collections and the need to
refrain from eating and drinking for a prolonged period created
further disruptions in their day, such as finding time to eat and
shower. Given challenges with saliva collection, some caregivers
shared that if possible, they would have preferred use of urine,
blood, or stool.

Caregivers’ Perspectives on Data Collection
Deductive content analysis of semi-structured interviews yielded
the categories and sub-categories displayed in Table 3 along
with corresponding exemplar quotations. Overall, caregivers
perceived the saliva collection protocol as stressful for themselves
and their child. While caregivers expressed a clear desire to
provide and obtain saliva samples for the study, they also found
the process to be challenging. All of the children experienced
difficulty providing saliva samples using the passive drool
technique. And, although the actual collection procedure was not
Frontiers in Psychology | www.frontiersin.org
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subcategory

Phase Two Analyses: Secondary Aims
Caregivers’ Perceptions of AME Benefits
Based on the analysis of transcribed semi-structured interviews,
the AME intervention, adapted to the longer stay associated
with HSCT, was a positive and beneficial experience (Table 3).
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children with data exceeding the feasibility threshold (child 3 and
4) to compare pre- and post-session distress scores. Levels of
child distress reported for child 3 were lower at post-session than
at pre-session at a level that was nearly significant (T = −1.00,
SD = 0.51, z = −1.96, p = 0.050); a similar pattern was not
observed for child 4 (T = −0.22, SD = 0.51, z = −0.44, p = 0.663).
No serial conditioning effects were detected in pre-session levels
of distress child 3 (T = −0.67, SD = 0.64, z = −1.04, p = 0.296) or
child 4 (T = −0.33, SD = 0.64, z = −0.52, p = 0.602); therefore, no
corrections for such effects were required.

Caregivers noted marked improvement in their child’s emotional
and physical distress both during and after AME sessions.
Caregivers reported that the opportunity to witness their child
become happy and playful (when they had previously been
withdrawn, in pain, and/or experiencing nausea) eased their own
distress, and provided ways to connect with and support their
child. In addition, session planning sheets, parent tip sheets, and
the music resource kit functioned as intended – parents shared
that these resources raised awareness and provided skills and
resources to successfully manage their child’s distress outside of
therapist-led sessions. Not only did parents find ways to use
music, but they also witnessed their child using music to selfmanage their own distress.
The proportion of data available for the proxy-report
ESAS measures regarding child distress exceeded the feasibility
threshold for dyads 3 and 4, and therefore these data were subject
to analyses as described above. As can be seen in Figure 5, total
symptom distress scores reported by caregivers for their children
were lower at post-session than at pre-session for both children
at each assessment. Values of Tau-U were calculated for the two

Differences in HPA-Axis Activity
Our analyses were confined to the viable blood samples collected
from all four children and the saliva samples collected from three
caregivers. Table 4 reports the blood cortisol concentrations for
child, while Figure 6 provides a visualization of the data for
the three children for whom the proportion of viable samples
exceeded the feasibility threshold. An inspection of this figure
suggests two patterns in the data: first, regardless of condition
(treatment or control), cortisol concentrations increased over

FIGURE 5 | Child ESAS scores (as reported by caregivers).
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at the trend level (T = −1.00, SD = 0.65, z = −1.55, p = 0.121).
Similar differences were not observed for the caregivers of Child
3 or 4 (for both, T = 0, SD = 0.65, z = 0, p = 1). As in the case for
blood samples, no serial conditioning effects were detected across
control condition days (for all children, T = −1.00, SD = 1.00,
z = −1.00, p = 0.317).

TABLE 4 | Blood cortisol concentrations.
Subject

Collection pair

Salivary cortisol concentration (µg/dL)
Control condition

1

2

3

4

1
2
3
4
1
2
3
4
1
2
3
4
1
2
3
4

0.50
9.40
8.30
3.20
---1
---1
22.90
0.40
5.10
28.10
31.70
11.20
5.00
1.10
0.70
6.00

Treatment condition
0.60
10.50
17.90
5.30
---1
---1
9.90
---1
13.70
14.30
31.30
20.80
1.70
4.70
10.60
1.00

DISCUSSION
The current study was designed to address two sets of aims.
The first set of aims concerned the feasibility/acceptability of
implementing the AME intervention during HSCT and collecting
data from young children (age 3 to 8 years) in this clinical context,
and the first question among these aims was whether a sufficient
proportion of eligible caregiver-child dyads would consent to
participate in the study. The fact that over a 4-month period 100%
of eligible caregiver-child dyads agreed to participate in our study
(exceeding our feasibility threshold by 25%) strongly suggests
that although HSCT is a high-risk treatment characterized by
uncertainty and high symptom distress, caregivers of young
children (age 3.51 to 4.53) are willing to enroll and provide
biological samples making it possible to recruit a sample of
sufficient size for a SCD study. Moreover, the fact that nearly
85% of AME sessions occurred as scheduled indicates that it
is possible to implement the intervention while children are
undergoing this treatment.
Consent rates and session completion rates for this pilot
study are consistent with prior AME trials. In one prior pilot
study, we had 80% enrollment and 100% session completion rate
(Robb et al., 2017). In our current multi-site trial looking at
AME during a 3-day inpatient admission we had 79% enrollment
and 90% session completion, even at one of the participating
hospitals where music therapy was a new service. Recruitment
and informed consent were completed by a study member who
was not part of the clinical care team; however, the music
therapist had been working on the unit full-time for 5 years.
The opportunity to establish good working relationships with
bedside staff and the availability of music therapy as a support
service commonly seen on the unit may have contributed to high
session completion rates. In addition, although the majority of
participants were new to the music therapist, she had worked
with two families at some point prior to their transplant and
enrollment in the study. Finally, due to the nature of the
intervention, presentation of the AME study is often met with
a high level of interest from children and their caregivers.
Having established that participants can be recruited and the
intervention can be delivered, the next question was whether
data could be collected according to the study design. On this
point, our results were mixed. In the case of two dyads, caregivers
completed the self- and proxy-report measures of distress at
a rate that met our feasibility threshold. Where cortisol data
collection was concerned, each child provided all eight blood
samples, and for three children all samples were viable. Collecting
saliva samples from children proved difficult, such that only two
children provided any samples and in both cases the proportion
of samples provided fell well below the feasibility threshold.

1 Cortisol concentration was below the minimum detectable range of the assay
(0.40 µg/dL).

time among child 1 and child 3, peaking at time of the third
session, and then declining by the time of the fourth session.
A similar pattern was observed for child 4, but only for days
corresponding to the treatment condition. Second, there was no
consistent difference in cortisol levels between conditions within
pairs of days. The latter pattern was confirmed by the results of
the analyses using the Tau-U statistic, in which no contrasts were
significant for any subject (Child 1: T = 0.38, SD = 0.43, z = 0.87,
p = 0.866; Child 3: T = 0.13, SD = 0.43, z = 0.29, p = 0.773; Child
4: T = 0.13, SD = 0.43, z = 0.29, p = 0.773) or for the group of
subjects as a whole (T = 0.21, z = 0.83, p = 0.405). Note that no
serial conditioning effects were detected in cortisol levels across
control condition days for any child (Child 1: T = 0, SD = 0.49,
z = 0, p = 1; Child 3: T = 0.33, SD = 0.49, z = 0.68, p = 0.497; Child
4: T = 0, SD = 0.49, z = 0, p = 1), and therefore no corrections for
such effects were required.
The caregivers of children 2, 3, and 4 provided viable
cortisol samples for at least 18 (75%) of the 24 data collection
points. Salivary cortisol concentrations for each viable sample
are reported in Table 5 and visualized in Figure 7. Figure 7 also
displays the linear trend (depicted by a line of best fit) in cortisol
levels for every day on which at least two cortisol samples were
collected (which comprised all but one treatment condition day
across the three caregivers who provided salivary cortisol samples
and eight control condition days). As can be seen in the figure, on
each treatment condition day the nature of the linear trend was
toward lower levels of cortisol after the first, pre-AME sample was
taken, as indicated by the negative slope for the line of best fit. In
contrast, cortisol decreased after the first sample only on three
control condition days.
The areas under the curve with respect to increase (AUCI )
were calculated as described above and are reported in Table 5.
We then used these AUCI values to calculate Tau-U statistics. For
the caregiver of child 2, these analyses revealed that the AUCI was
smaller on treatment condition days than control condition days
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FIGURE 6 | Child blood cortisol concentrations.
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The secondary aims of the study were to assess the benefits
of AME via caregiver interviews, child ESAS scores, and
cortisol levels in children and their caregivers. Interview data
indicate the AME intervention was beneficial in reducing child
emotional and physical distress, both during and after therapistled sessions. In addition, caregivers experienced relief in seeing
these improvements in their child and reported that they and
their child used music-play activities and resources outside
session to manage distress. These findings suggest that AME
offers not only immediate relief during therapist-led sessions, but
that it also helped children and their caregivers learn to use new
strategies to manage their own distress between sessions.
In the case of the two children (child 3 and 4) whose caregivers
provided sufficient ESAS data, visual inspection and analyses of
child distress scores converged with those obtained from the
semi-structured interviews. In both cases, the child’s caregiver
consistently reported lower levels of child distress after the
AME occurred, relative to before. Interestingly, Child 3, who
had the most consistent (and significant) reduction in symptom
distress had one of the hardest courses of treatment – meaning
the child had an allogeniec transplant (which is associated
with more frequent and intense side effects, compared with
autologous transplants), and this child had Graft Versus Host
Disease (GVHD) that was Stage 4, Grade 3. GVHD is unique
to HSCT because it is essentially the immune system that is
being transplanted. This makes it possible for both the child’s
existing immune system to attack the new stem cells (graft failure)
and the newly transplanted immune system to attack the child’s
body (GVHD). Typical manifestation of GVHD includes skin
rash, liver dysfunction and gastrointestinal symptoms like pain,
nausea and diarrhea (Nassereddine et al., 2017). Future studies
that take into account diagnosis and treatment intensity may help
determine for whom AME is most beneficial.
Child 4 also had an allogeneic transplant, but for SCD.
This is important because children with SCD have typically not
yet encountered chemotherapy. While SCD is a disease with
high symptom burden already, chemotherapy and prolonged
hospitalization are difficult to prepare a family for. This
often leads to higher levels of uncertainty for both the child
and caregiver, and a potentially harder time adjusting to the
experience of these new, intense side-effects (Hulbert and
Shenoy, 2018). This is apparent in higher distress scores
at baseline (compared with Child 3), and may explain
markedly higher scores mid-treatment when symptom distress is
particularly difficult.
Our analyses of cortisol concentrations in blood samples for
the three children who provided samples revealed a consistent
pattern of cortisol over time, with cortisol levels increasing from
the first pair of data collection days to peak at the third pair, before
declining by the fourth pair (with the caveat that for one child
this pattern was observed only on treatment condition days).
This pattern is consistent with other studies examining distress
during HSCT, where distress increases over time as side-effects
from and ambiguity about treatment outcomes increase, and then
has a gradual decline toward the end of treatment as severity
of symptoms decreases and counts stabilize (Phipps et al., 2002;
Vrijmoet-Wiersma et al., 2009). There were also no differences in

TABLE 5 | Salivary cortisol concentrations and areas under the curve.
Subject

Collection
pair

Condition

Salivary cortisol concentration
(ng/mL)
PreAME

2

1
2
3
4

3

1
2
3
4

4

1
2
3
4

PostAME 1

PostAME 2

AUCI

Control

0.20

—

—

—

Treatment

2.20

1.33

0.74

−1.60

Control

0.69

3.58

1.37

3.23

Treatment

1.29

0.27

0.30

−1.52
−5.48

Control

5.11

1.88

0.61

Treatment

5.10

—

—

Control

1.28

1.32

1.41

0.11

Treatment

3.52

0.77

0.63

−4.20

Control

—

—

—

—

Treatment

4.65

2.85

1.17

−3.54

—

Control

11.13

3.06

1.22

−13.03

Treatment

2.47

1.54

1.37

−1.48

Control

—

—

—

—

Treatment

5.36

2.13

0.92

−5.45

Control

3.43

1.81

7.99

0.66

Treatment

7.99

7.57

0.25

−4.29
—

Control

1.20

1.71

—

Treatment

2.92

—

1.70

—

Control

1.75

1.05

1.50

−0.83

Treatment

1.80

1.44

1.61

−0.46

Control

—

—

—

—

Treatment

2.39

1.33

1.15

−1.68

Control

2.71

2.14

0.99

−1.43

Treatment

2.83

1.65

1.14

−2.03

In contrast, caregivers provided 72% of the scheduled saliva
samples, which approached the feasibility threshold of 75%. The
difference in the proportion of samples provided by children
and their caregivers may be explained, in part, by the side
effects of HSCT, which include dry mouth and oral sores that
can discourage children from providing samples. In addition,
high symptom distress coupled with younger child age may
have contributed to lower sample acquisition. Although our
enrollment criteria included children age 3–8 years, the average
age for enrolled participants was 3.84 years making it impossible
to examine whether older children would have experienced
difficulty providing samples.
The results of the semi-structured interviews corroborate this
explanation for low rates of collection among children, and
also offer additional reasons that caregivers did not provide
saliva samples at every time point. Chief among these was the
fact the number and frequency of samples required by the
SCD interfered with caregivers’ schedules, preventing them from
drinking, eating, or showering over a number of hours. This,
together with the need to collect samples from the same caregiver
on each collection day across the 8 weeks of their participation
and that these data were being collected in the context of a highly
distressing treatment regimen (cf., Best et al., 2001; Virtue et al.,
2014) had a compounded effect that resulted in additional burden
for children and their caregivers.
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FIGURE 7 | Caregiver salivary cortisol concentrations.

levels of blood cortisol concentrations on treatment and control
condition days, though this must be interpreted with caution
due to the schedule of the SCD. It is possible that on control
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condition days falling the day after a treatment day levels of
morning cortisol are lower due to the AME session that occurred
the day before; similarly, higher levels of morning cortisol on
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neurophysiological system in which change occurs gradually.
Some parents delayed self-care activities, such as taking a shower,
in anticipation of a scheduled collection. As such, reassuring
parents that these activities will not interfere with collection is
important. Allowing a caregiver to take a shower before providing
a sample is acceptable, assuming the shower does not last for
more than approximately 20 min. Similarly, allowing a parent to
eat or drink in between samples is fine, as long as they do not
do so immediately before providing a sample and try to avoid
certain items that will contaminate the sample (e.g., highly-acidic
beverages, such as orange juice).
It may be worthwhile to consider using additional or
alternative stress biomarkers for use with children and/or
caregivers. Collecting other biomarkers that are sequestered in
saliva will pose precisely the same challenges as collecting salivary
cortisol, and while it may be possible to collect blood samples
from caregivers, the frequency with which those samples would
have to be collected to support a SCD may be problematic.
However, like the HPA axis, the autonomic nervous system
(ANS) is highly responsive to stress, and there are many noninvasive measures of ANS activity that could serve as a stress
biomarker. These include measures of global ANS activity, such
as blood pressure, as well as more specific measures of the ANS’
two branches, the parasympathetic and sympathetic nervous
systems, both of which can be indexed via cardiac monitoring.
Finally, as demonstrated in this pilot study, despite our focus
on understanding the biological effects of active music on child
and caregiver stress it is important to include brief symptom
distress measures that are sensitive to change and to conduct
participant interviews. As with any measure there are limitations;
therefore, it is essential that investigators use diverse forms of
measurement and inquiry to fully capture changes in child and
caregiver distress.

treatment days may reflect the fact that AME did not occur on
the previous day and had yet to occur on that day.
Our analysis of salivary cortisol samples provided by the
three caregivers who met our feasibility threshold revealed that
caregivers were more likely to exhibit decreases in cortisol on
days they participated in an AME than on days when they did
not. This suggests that AME may have some impact on caregivers’
patterns of diurnal HPA-axis activity, or at least the portion of
that activity which coincided with the times of day when samples
were collected. To the extent that this activity reflects caregivers’
perceived stress, the AME intervention may have the potential to
lower caregivers’ stress levels, a possibility that is congruent with
the results obtained from semi-structured interviews conducted
with caregivers. However, it must also be noted that only one
caregiver was found to have systematically lower aggregate or
overall levels of cortisol on treatment days relative to control days,
and that this difference was observed at the trend level. It may
therefore be the case that while AME has the potential to change
the slope of caregivers’ diurnal cortisol, that change is not large
enough to result in systematic differences in the overall level of
cortisol produced.

Limitations and Future Directions
Our results clearly indicate that it is feasible to implement the
AME intervention in the context of HCST. The results about
collecting data with sufficient frequency to execute a SCD were
mixed, as were the results about the benefits of AME that this
design yielded. The mixed results regarding the benefits of AME
clearly call for additional research. The question is what form that
research should take. A randomized control trial (RCT) offers the
same protections against threats to internal validity provided by a
SCD, and is therefore an appealing option. The problem is that an
RCT investigation into the benefits of AME would be very likely
to be under-powered due to the low incidence rate of pediatric
patients (age 3–8 years) undergoing use of HCST (Transplant
Activity Report, 2019).
The question then becomes how to modify the procedures for
a SCD study to minimize both the burden that data collection
places on families and the amount of missing data. One clear
lesson from the current study is that collecting salivary cortisol
samples from younger children (age 3–4) in this treatment setting
is infeasible. Another is that interpreting a single, waking blood
cortisol sample is problematic. Taking one additional blood
sample after the AME session occurred (and at the same times
on control-condition days) would allow for a comparison of
diurnal activity across conditions, which could be more readily
interpreted. The caveat is that collecting additional blood samples
can elevate the risk of infection, and so this additional sample
would ideally coincide with blood draws for usual monitoring
during transplant and must be taken in consideration with the
appropriate weight-based thresholds in daily blood draws for
younger patients (cf., Peplow et al., 2019).
Similar adjustments to collecting salivary cortisol samples
from caregivers are warranted. Some caregivers disliked the
passive drool method of saliva collections describing the
process as “gross.” Switching to oral swabs is therefore
recommended. It is also important to allow more flexibility in the
collection schedule with caregivers. The HPA axis is a sluggish
Frontiers in Psychology | www.frontiersin.org

CONCLUSION
This study investigated whether cortisol could be used as a
stress biomarker in a SCD study to explore the effects of
AME on children undergoing HSCT, as well as their caregivers.
Our results suggest that it is possible to recruit a sufficient
number of families to participate in such a study, and that
the AME can be implemented as designed. However, they
also suggest that collecting salivary cortisol from children and
caregivers with the frequency required for a SCD creates
additional burden for families already undergoing a difficult
treatment. Nevertheless, we found that families are eager to
participate in the study of an intervention they value and provide
biological samples which underscores the need for devising more
innovative, less burdensome approaches for understanding the
neurophysiological impacts of AME in future research.
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